Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC jointly reported beneficial ownership of 90,987 shares in Phio Pharmaceuticals, representing approximately 4.99% of the company's common stock. The calculation is based on 1,492,411 shares outstanding as of December 23, 2024, plus 240,000 shares issued at the closing of a recent Securities Purchase Agreement.The reporting persons hold shared voting and dispositive power over all 90,987 shares, with no sole voting or dispositive power. Their ownership is subject to blocker provisions limiting exercise rights to maintain ownership below 4.99%. Without these blocker provisions, the reporting persons could potentially own up to 431,012 shares through various warrants, including Intracoastal Warrants 1-4.

Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC jointly reported beneficial ownership of 90,987 shares in Phio Pharmaceuticals, representing approximately 4.99% of the company's common stock. The calculation is based on 1,492,411 shares outstanding as of December 23, 2024, plus 240,000 shares issued at the closing of a recent Securities Purchase Agreement.The reporting persons hold shared voting and dispositive power over all 90,987 shares, with no sole voting or dispositive power. Their ownership is subject to blocker provisions limiting exercise rights to maintain ownership below 4.99%. Without these blocker provisions, the reporting persons could potentially own up to 431,012 shares through various warrants, including Intracoastal Warrants 1-4.